Comments on the FDA's guidance for industry on off label marketing

Yesterday I reported that the FDA has issued a final "Guidance for Industry" which provides "the agency's views on the distribution of medical journal articles and scientific or medical reference publications that discuss unapproved new uses" for FDA-approved drugs and medical devices. Today, the folks at the Drug and Device Blog have posted a long comment on it. It is available here.